Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
910 | 10558 | 38.5 | 65% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
530 | 17046 | PRIMARY BILIARY CIRRHOSIS//AUTOIMMUNE HEPATITIS//PRIMARY SCLEROSING CHOLANGITIS |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
2254 | 2234 | FARNESOID X RECEPTOR//FXR//TGR5 |
3898 | 1813 | BILITRANSLOCASE//CANALICULAR MEMBRANE//HEPATOCYTE COUPLETS |
6911 | 1352 | CALCULUS BOVIS//SULFATED BILE ACID//URINARY SULFATED BILE ACID |
7035 | 1338 | INTRAHEPATIC CHOLESTASIS OF PREGNANCY//PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS//ABCB11 |
7986 | 1229 | FECAPENTAENES//FAECAL WATER//DEOXYCHOLATE |
12523 | 837 | URSODEOXYCHOLIC ACID//TAUROURSODEOXYCHOLIC ACID//TAUROURSODEOXYCHOLATE |
16711 | 575 | INTRAHEPATIC BILIARY EPITHELIUM//SCOTT WHITE DIGEST DIS//CENT TEXAS VET HLTH CARE SYST |
19061 | 457 | CEREBROTENDINOUS XANTHOMATOSIS//CHOLESTANOL//BILE ALCOHOLS |
20944 | 379 | 7 ALPHA DEHYDROXYLATION//7 ALPHA HYDROXYSTEROID DEHYDROGENASE//CLOSTRIDIUM SCINDENS |
21900 | 344 | BILE ACID MALABSORPTION//SEHCAT//75SEHCAT |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BILE ACIDS | Author keyword | 364 | 40% | 7% | 721 |
2 | FARNESOID X RECEPTOR | Author keyword | 208 | 70% | 2% | 172 |
3 | CEREBROTENDINOUS XANTHOMATOSIS | Author keyword | 189 | 83% | 1% | 107 |
4 | BILE ACID | Author keyword | 162 | 37% | 3% | 357 |
5 | CHOLESTASIS | Author keyword | 136 | 24% | 5% | 496 |
6 | INTRAHEPATIC CHOLESTASIS OF PREGNANCY | Author keyword | 128 | 79% | 1% | 81 |
7 | URSODEOXYCHOLIC ACID | Author keyword | 123 | 35% | 3% | 281 |
8 | PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS | Author keyword | 118 | 84% | 1% | 64 |
9 | FXR | Author keyword | 115 | 61% | 1% | 122 |
10 | BILE ACID SYNTHESIS | Author keyword | 101 | 71% | 1% | 82 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BILE ACIDS | 364 | 40% | 7% | 721 | Search BILE+ACIDS | Search BILE+ACIDS |
2 | FARNESOID X RECEPTOR | 208 | 70% | 2% | 172 | Search FARNESOID+X+RECEPTOR | Search FARNESOID+X+RECEPTOR |
3 | CEREBROTENDINOUS XANTHOMATOSIS | 189 | 83% | 1% | 107 | Search CEREBROTENDINOUS+XANTHOMATOSIS | Search CEREBROTENDINOUS+XANTHOMATOSIS |
4 | BILE ACID | 162 | 37% | 3% | 357 | Search BILE+ACID | Search BILE+ACID |
5 | CHOLESTASIS | 136 | 24% | 5% | 496 | Search CHOLESTASIS | Search CHOLESTASIS |
6 | INTRAHEPATIC CHOLESTASIS OF PREGNANCY | 128 | 79% | 1% | 81 | Search INTRAHEPATIC+CHOLESTASIS+OF+PREGNANCY | Search INTRAHEPATIC+CHOLESTASIS+OF+PREGNANCY |
7 | URSODEOXYCHOLIC ACID | 123 | 35% | 3% | 281 | Search URSODEOXYCHOLIC+ACID | Search URSODEOXYCHOLIC+ACID |
8 | PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS | 118 | 84% | 1% | 64 | Search PROGRESSIVE+FAMILIAL+INTRAHEPATIC+CHOLESTASIS | Search PROGRESSIVE+FAMILIAL+INTRAHEPATIC+CHOLESTASIS |
9 | FXR | 115 | 61% | 1% | 122 | Search FXR | Search FXR |
10 | BILE ACID SYNTHESIS | 101 | 71% | 1% | 82 | Search BILE+ACID+SYNTHESIS | Search BILE+ACID+SYNTHESIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FARNESOID X RECEPTOR | 398 | 58% | 4% | 460 |
2 | SALT EXPORT PUMP | 318 | 55% | 4% | 395 |
3 | FXR | 278 | 73% | 2% | 210 |
4 | FAMILIAL INTRAHEPATIC CHOLESTASIS | 270 | 58% | 3% | 308 |
5 | CHENODEOXYCHOLIC ACID | 248 | 52% | 3% | 339 |
6 | OBSTETRIC CHOLESTASIS | 239 | 86% | 1% | 120 |
7 | BILE ACIDS | 206 | 24% | 7% | 741 |
8 | URSODEOXYCHOLIC ACID | 182 | 26% | 6% | 609 |
9 | BILE ACID RECEPTOR | 168 | 81% | 1% | 100 |
10 | NEGATIVE FEEDBACK REGULATION | 166 | 63% | 2% | 166 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROGRESS IN LIVER DISEASES | 2 | 15% | 0% | 11 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Bile acid receptors as targets for drug development | 2014 | 36 | 159 | 65% |
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation | 2009 | 386 | 342 | 64% |
Targeting bile-acid signalling for metabolic diseases | 2008 | 288 | 145 | 76% |
Bile acid signaling and liver regeneration | 2015 | 7 | 73 | 64% |
Bile acids: regulation of synthesis | 2009 | 217 | 147 | 76% |
Bile acids: Chemistry, pathochemistry, biology, pathobiology, and therapeutics | 2008 | 223 | 88 | 63% |
Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis | 2015 | 4 | 60 | 72% |
The bile acid TGR5 membrane receptor: From basic research to clinical application | 2014 | 16 | 84 | 71% |
Bile acids as regulatory molecules | 2009 | 183 | 89 | 72% |
Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy | 2014 | 11 | 76 | 88% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MATERNAL FETAL DIS GRP | 29 | 88% | 0.1% | 14 |
2 | EXPT MOL HEPATOL | 28 | 52% | 0.4% | 38 |
3 | SCOTT WHITE DIGEST DIS | 23 | 62% | 0.2% | 24 |
4 | CENT TEXAS VET HLTH CARE SYST | 18 | 44% | 0.3% | 31 |
5 | EXPT HEPATOL DRUG TARGETING | 12 | 48% | 0.2% | 19 |
6 | GENE REGULAT DRUG DISCOVERY | 12 | 49% | 0.2% | 18 |
7 | DEV MOL HEPATOL | 11 | 78% | 0.1% | 7 |
8 | EXPT HEPATOL DRUG TARGETING HEVEFARM | 10 | 52% | 0.1% | 13 |
9 | BILE ACID | 9 | 83% | 0.0% | 5 |
10 | PHARMACEUT DEV PHYS PROPERTIES DEVELOPABIL | 9 | 83% | 0.0% | 5 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000015450 | PRIMARY BILIARY CIRRHOSIS//AUTOIMMUNE HEPATITIS//PRIMARY SCLEROSING CHOLANGITIS |
2 | 0.0000009712 | CHOLEDOCHOLITHIASIS//CHOLANGIOCARCINOMA//GALLSTONES |
3 | 0.0000009574 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//ABCG2 |
4 | 0.0000009305 | PLANT STEROLS//PHYTOSTEROLS//SITOSTANOL |
5 | 0.0000008797 | DMP 504//POLYCATIONIC SALTS//GROSS HEAT VALUE |
6 | 0.0000007834 | REGUCALCIN//SMP30//ENDOCRINOL MOL METAB |
7 | 0.0000007747 | ADRENOLEUKODYSTROPHY//FATTY ACID BINDING PROTEIN//X LINKED ADRENOLEUKODYSTROPHY |
8 | 0.0000007414 | KERNICTERUS//BILIRUBIN//HYPERBILIRUBINEMIA |
9 | 0.0000007135 | PORTOSYSTEMIC SHUNT//VET CARDIOVASC UNIT//ORNITHINE CARBAMYLTRANSFERASE |
10 | 0.0000007062 | PEPT1//PEPT2//HPEPT1 |